Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of a DNA vaccine expressing a human immunodeficiency virus-like particle.

Virology - 1 Oct 2004

Young Kelly R, Smith James M, Ross Ted M

Abstract excerpt

An ideal human immunodeficiency virus type-1 (HIV-1) vaccine will most likely need to elicit cross-reactive neutralizing antibodies and a strong cell-mediated immune response against multiple HIV-1 antigens to confer protection against challenge. In this study, DNA vaccines were constructed to express virally regulated human immunodeficiency virus-like particles (VLP) to elicit broad-spectrum immune responses to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AIDS Vaccines
Share to CD4 Antigens
Share to COS Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Antigens

Share to Retroviridae Proteins

Share to Vaccines, DNA

Share to Viral Regulatory and Accessory Proteins

Share to Virion

Source

Identifiers

PMID: 15351214
DOI: 10.1016/j.virol.2004.07.009

Genes

CD4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of a DNA vaccine expressing a human immunodeficiency virus-like particle.PMID 15351214Read ↗

A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector systemSemantic proximity Read ↗

Modifications of the Human Immunodeficiency Virus Envelope Glycoprotein Enhance Immunogenicity for Genetic ImmunizationSemantic proximity Read ↗

Virus-like particles: Designing an effective AIDS vaccineSemantic proximity Read ↗

HIV DNA Vaccine: Stepwise Improvements Make a DifferenceSemantic proximity Read ↗

Can we use structural knowledge to design a protective vaccine against HIV-1?Semantic proximity Read ↗

HIV-1 vaccine immunogen design strategiesSemantic proximity Read ↗

The changing face of HIV vaccine research.Semantic proximity Read ↗

Generating and measuring effective vaccine-elicited HIV-specific CD8+ T cell responsesSemantic proximity Read ↗

DNA vaccines for viral diseasesSemantic proximity Read ↗

Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus MacaquesSemantic proximity Read ↗

Elicitation of Neutralizing Antibodies with DNA Vaccines Expressing Soluble Stabilized Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trimers Conjugated to C3dSemantic proximity Read ↗

A Tetravalent Dengue Virus-like Particle Vaccine Induces High levels of Neutralizing Antibodies and Inhibits Dengue Replication in Non-Human PrimatesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.